---
format: "aidr-story-markdown/v1"
id: "617d26824a24dca04d593d46661c47326435624666ad1baadb687760fc16ea01"
canonical_url: "https://aidr.today/617d2682?lang=en"
title: "Helios Raises $2.3M for At-Home Blood Test Launching in 2027"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-11-21T01:22:04.000Z"
category: "Funding"
topics: ["funding"]
source_urls: ["https://marketbrief.now/startups/helios-raises-23m-for-at-home-blood-test-launching-in-2027-0faf5214","https://huggingnews.com/startups/helios-raises-23m-for-at-home-blood-test-launching-in-2027-0faf5214"]
summary: "Helios raised $2.3 million in seed funding to develop a needle-free, at-home blood test scheduled to launch in 2027. The company's proteomics platform measures more than 1,000 proteins from a single drop of blood. The system claims it can spot early signs of ALS and blood cancers and may flag dementia risk as early as 15 years before a diagnosis."
---

# Helios Raises $2\.3M for At\-Home Blood Test Launching in 2027

> [Open the canonical story](<https://aidr.today/617d2682?lang=en>)

**Published:** 2026-11-21T01:22:04.000Z
**Category:** Funding
**Topics:** funding

## Summary

Helios raised $2\.3 million in seed funding to develop a needle\-free, at\-home blood test scheduled to launch in 2027\. The company's proteomics platform measures more than 1,000 proteins from a single drop of blood\. The system claims it can spot early signs of ALS and blood cancers and may flag dementia risk as early as 15 years before a diagnosis\.

## Sources

- [Story source](<https://marketbrief.now/startups/helios-raises-23m-for-at-home-blood-test-launching-in-2027-0faf5214>)
- [Story source](<https://huggingnews.com/startups/helios-raises-23m-for-at-home-blood-test-launching-in-2027-0faf5214>)

